GliPR inhibitors (L2 Diagnostics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGliPR inhibitors (L2 Diagnostics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlioma pathogenesis-related protein 1 inhibitors
TargetsGlioma pathogenesis-related protein 1
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesL2 Diagnostics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesL2 Diagnostics LLC
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A